Insiders · EVMN

Eugene Bauer

Chief Medical Officer, Director at Evommune, Inc. (EVMN)

Eugene Bauer has filed 5 insider reports with the SEC since May 2021, as chief Medical Officer and director at Evommune, Inc. (EVMN) and director at Kadmon Holdings, Inc. (KDMN). The latest filing, on April 17, 2026, reports grant or award at Evommune, Inc. (EVMN).

Filings
5
Companies
2
Bought on market
None
Sold on market
None

Companies where Eugene Bauer is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
EVMN Evommune, Inc.Chief Medical Officer, Director270,818$7.65Apr 17, 2026
KDMN Kadmon Holdings, Inc.Director0Nov 9, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Eugene Bauer.

Compare Eugene Bauer with

Other insiders at the same companies

Questions about Eugene Bauer

What is Eugene Bauer's role at Evommune, Inc.?
Eugene Bauer reports to the SEC as chief Medical Officer and director at Evommune, Inc. (EVMN), according to the latest filing on April 17, 2026. Eugene Bauer has also filed as director at Kadmon Holdings, Inc. (KDMN).
How many shares does Eugene Bauer own?
After the latest filing that states it, Eugene Bauer directly owned 270,818 shares of Evommune, Inc. (EVMN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eugene Bauer bought or sold stock recently?
No open-market purchases or sales by Eugene Bauer are on file. The filings report grant or award, shares withheld for taxes or exercise price and sale back to the company.
How do I get alerts when Eugene Bauer files?
Follow Eugene Bauer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eugene Bauer (SEC CIK 0001678620). Totals count each trade once, skipping amendments whose original is on file, from May 13, 2021 on. View on SEC EDGAR